Explore 3 Stock Ideas & Industry Insights Download Free Report
Fusion Antibodies (LSE:FAB) is included in this fresh batch of UK corporate-news coverage for 15 October 2026.
Scancell Holdings (LSE:SCLP) is included in this fresh batch of UK corporate-news coverage for 15 October 2026.
SkinBioTherapeutics (LSE:SBTX) is included in this fresh batch of UK corporate-news coverage for 15 October 2026.
After more than a year of strategic review, failed talks and shareholder pressure, Spire Healthcare (LSE: SPI) appears to be approaching the end of its life as a listed company. The FTSE 250 group has agreed to a takeover by Tulip UK Bidco, a …
The gene and cell therapy contract manufacturer has spent the past two months trying to rebuild confidence after a difficult summer. On 7 August, Oxford BioMedica (LSE: OXB) told the market that full-year 2026 revenue would come in at£180m to £200mon a constant-currency basis, …
Oxford Nanopore Technologies plc (LSE: ONT) has given investors a turbulent ride in 2026. The FTSE 250 life sciences company, which develops portable DNA and RNA sequencing devices, saw its shares slump in July after warning on first-half revenue, only to rally strongly in …
Ondine develops light-activated antimicrobial therapies, which it calls photodisinfection, to prevent and treat infections. Its lead product, Steriwave, is used for nasal decolonisation to reduce the risk of infection in surgical and intensive care patients. It is authorised in Canada, the UK and certain …
OptiBiotix is a life sciences company developing products that aim to reduce hunger and cravings, support the gut microbiome and replace sugar with sweet fibres. Its first-generation products include SlimBiome, used in weight management, and WellBiome, aimed at gut and digestive health. SweetBiotix is …
Arecor Therapeutics (LSE:AREC) is in focus on 15 October 2026 following a fresh corporate development.
Fusion Antibodies is a contract research organisation focused on antibody engineering. It provides services such as antibody humanisation, sequencing and stable cell line development to pharmaceutical and biotechnology clients, many of them in North America. In recent years it has been building proprietary technology, …
We use some essential cookies to make this site work. We also set analytics and marketing cookies, described below, to understand how you use the site and to measure our advertising. For more detailed information, see our Cookie Policy, Privacy Policy and Terms and Conditions.
These cookies are necessary for core functionality, such as security, your shopping cart, remembering your cookie choice, and your progress through a report or free-trial request you started. They always need to be on.
We use analytics cookies to understand how visitors use the site — the pages visited, time spent, and where visitors came from.
These help us measure how effective our advertising is, such as recording actions you take after clicking one of our ads. If you don't enable this, you may still see our ads, but they won't be measured this way.
Please wait processing your request...
You are not subscribed for this report, Want to See?
One of our sales representative will contact you soon!
Welcome to Kalkine!
Download Free Report
Hi! How can we help you today?
Loading…